Antimicrobial resistance (AMR) has been identified as one of the most urgent issues facing global health. LMIC will disproportionately be affected, because of the tremendous burden of infectious diseases coupled with critical gaps in diagnostic infrastructure, infection control, antimicrobial stewardship, regulatory access and governance.
This 1-day workshop will focus on resistance to antimicrobials and approaches to tackling misuse of antibiotics in different medical settings. The workshop format is a mix of plenary talks and panel discussions, with opportunities to interact with participants who work across the spectrum of the antimicrobial resistance space in different countries.
Clinicians, researchers, implementers, and health educators from both high-income and LMIC will share questions, successes, and lessons learned to advance the field of AMR.
Peter Dailey, PhD, MPH – UC Berkeley
Louis-Patrick Haraoui, MD MSc – Université de Sherbrooke
Christian Lavallée, MD – Université de Montréal
Admasu Tenna Mamuye, MD MSc – Addis Ababa University
Marc Mendelson, MD – University of Cape Town
Mark Miller, MD, MSc – bioMerieux
Yoshiko Nakamachi, RN, BScN, BA, PMP – University Health Network
Jean-Baptiste Ronat, MSc MPH, Médecins Sans Frontières (MSF), Paris
Jorg Janne Vehreschild, MD – University of Cologne
Erika Vlieghe, MD – Institute Tropical Medicine and University of Antwerp
Kamini Walia, PhD, MPH – Indian Council of Medical Research
Cédric Yansouni, MD, FRCPC, DTM&H – McGill University
Faculty members are still being confirmed and there may be changes to the above list
- Convene key stakeholder groups to create a platform for information exchange and knowledge transfer on AMR particularly in LMIC
- Stimulate discussions on practical measures to tackle AMR in LMIC, both in the hospital setting and in the community
- Propose approaches to accelerate implementation of stewardship measures including diagnostics and analytics.
This course appeals to a wide range of participants including:
- Clinicians, pharmacists, technologists, researchers and students studying infectious diseases, tropical medicine, or global health
- Policy makers and public health agency officials
- Product developers and funders
- Community advocacy groups working in global health
Maximum of 100 participants.